PAOG Coronavirus Treatment Acceleration Program Application Updates Covered In CEO Interview For Release Tomorrow
August 06 2020 - 10:31AM
InvestorsHub NewsWire
Sandusky, OH -- August 6, 2020 --
InvestorsHub NewsWire -- PAO Group, Inc. (USOTC:
PAOG) today announced an interview of
CEO James C. DiPrima on MoneyTV with Donald Baillargeon is
scheduled for release tomorrow, August 7, 2020. Mr. DiPrima
also appeared on MoneyTV last week following PAOG’s acquisition of
two medical cannabis
companies.
Highlights of the interview to be released
include PAOG’s soon anticipated entry into a Contract Research
Organization (CRO) agreement in conjunction with
advancing an Investigational New Drug
Application (IND) to ultimately achieve Food and
Drug Administration (FDA) approval for RespRx
(one of the two acquisitions executed by PAOG last week) as a COPD
treatment.
Based on
positive results from an informal trial of RexpRx with 25 COVID-19
patients, PAOG also plans to make Coronavirus Treatment
Acceleration Program (CTAP) application after
entering into a CRO
agreement.
The COPD treatment, RespRx, is derived
from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled “METHOD AND
APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE
CANNABIS PLANT.”
MoneyTV with
Donald Baillargeon is the internationally syndicated television
program all about money and what makes it happen, featuring
informative interviews with company CEOs and executives, providing
insights into their operations and outlooks for their futures.
MoneyTV is seen in over 200 million TV households in more than 75
countries.
The MoneyTV
Interview is available at www.moneytv.net and will be syndicated across multiple channels
and platforms.
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this release.
CONTACT
INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
info@pao.group
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Mar 2024 to Apr 2024
PAO (PK) (USOTC:PAOG)
Historical Stock Chart
From Apr 2023 to Apr 2024